224 studies found for:    "Medulloblastoma"
Show Display Options
Rank Status Study
1 Recruiting A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Condition: Medulloblastoma
Interventions: Radiation: Craniospinal Irradiation with boost to the primary tumor site;   Drug: Cyclophosphamide;   Drug: Cisplatin;   Drug: Vincristine;   Drug: Vismodegib;   Drug: Pemetrexed;   Drug: Gemcitabine;   Other: Aerobic Training;   Other: Neurocognitive Remediation
2 Completed TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma;   Relapse
Intervention: Drug: TPI 287
3 Recruiting Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
Conditions: Medulloblastoma;   Neuroectodermal Tumor
Interventions: Biological: TTRNA-xALT;   Biological: TTRNA-DCs
4 Active, not recruiting Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults
Condition: Medulloblastoma
Interventions: Drug: maintenance chemotherapy (vincristin, cisplatin and CCNU);   Radiation: Radiotherapy
5 Recruiting Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma
Condition: Medulloblastoma
Interventions: Drug: Bevacizumab;   Drug: Thalidomide;   Drug: Celecoxib;   Drug: Fenofibric acid;   Drug: Etoposide;   Drug: Cyclophosphamide;   Drug: Etoposide phosphate;   Drug: Liposomal cytarabine
6 Active, not recruiting A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
Condition: Medulloblastoma
Intervention: Drug: LDE225
7 Recruiting Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
Condition: Medulloblastoma
Interventions: Drug: Lomustine;   Drug: Vincristine;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Mesna
8 Withdrawn A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma
Conditions: Medulloblastoma, Childhood;   Rhabdomyosarcoma
Intervention: Drug: LY2940680
9 Terminated Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma
Conditions: Brain Tumors;   Central Nervous System Tumors;   Medulloblastoma;   Primitive Neuroectodermal Tumor
Interventions: Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Lomustine;   Drug: Vincristine;   Drug: Mesna;   Radiation: Craniospinal Radiation
10 Recruiting Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway
Conditions: Histologically Confirmed Medulloblastoma;   Activation of the Sonic Hedgehog (SHH) Pathway
Interventions: Drug: vismodegib;   Drug: Temozolomide
11 Recruiting Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma
Condition: Medulloblastoma
Intervention:
12 Recruiting Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma
Conditions: Brain Tumor;   Medulloblastoma;   Pineoblastoma
Intervention: Radiation: proton beam radiation
13 Terminated Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma
Intervention: Drug: TPI 287
14 Recruiting Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma
Interventions: Drug: Nifurtimox;   Drug: Cyclophosphamide;   Drug: Topotecan
15 Recruiting Radiation Therapy and Combination Chemotherapy for Medulloblastoma
Condition: Medulloblastoma
Interventions: Drug: Temozolomide;   Radiation: Craniospinal Radiation
16 Recruiting Trial of Tolcapone With Oxaliplatin for Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma
Interventions: Drug: Tolcapone;   Drug: Oxaliplatin
17 Active, not recruiting Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma
Condition: Medulloblastoma
Interventions: Radiation: Standard Fractionation Regimen;   Radiation: Hyperfractionated Radiotherapy
18 Terminated Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Conditions: Gliomas;   Medulloblastoma;   Neuroectodermal Tumors, Primitive
Interventions: Biological: Vaccine (autologous dendritic cells);   Drug: Decitabine and Hiltonol
19 Recruiting Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
Condition: Medulloblastoma
Interventions: Drug: carboplatine;   Drug: Etoposide;   Radiation: radiation therapy
20 Recruiting HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Conditions: Medulloblastoma;   Central Nervous System Embryonal Tumors
Interventions: Drug: Induction;   Drug: Single Cycle Intensive Chemotherapy;   Drug: Tandem 3 Cycle Intensive Chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years